Cargando…

Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys

Growing evidence suggests that renal purinergic signaling undergoes significant remodeling during pathophysiological conditions such as diabetes. This study examined the renal P2 receptor profile and ATP-mediated calcium response from podocytes in glomeruli from kidneys with type 1 or type 2 diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Palygin, Oleg, Klemens, Christine A., Isaeva, Elena, Levchenko, Vladislav, Spires, Denisha R., Dissanayake, Lashodya V., Nikolaienko, Oksana, Ilatovskaya, Daria V., Staruschenko, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188476/
https://www.ncbi.nlm.nih.gov/pubmed/34142040
http://dx.doi.org/10.1016/j.isci.2021.102528
_version_ 1783705336709906432
author Palygin, Oleg
Klemens, Christine A.
Isaeva, Elena
Levchenko, Vladislav
Spires, Denisha R.
Dissanayake, Lashodya V.
Nikolaienko, Oksana
Ilatovskaya, Daria V.
Staruschenko, Alexander
author_facet Palygin, Oleg
Klemens, Christine A.
Isaeva, Elena
Levchenko, Vladislav
Spires, Denisha R.
Dissanayake, Lashodya V.
Nikolaienko, Oksana
Ilatovskaya, Daria V.
Staruschenko, Alexander
author_sort Palygin, Oleg
collection PubMed
description Growing evidence suggests that renal purinergic signaling undergoes significant remodeling during pathophysiological conditions such as diabetes. This study examined the renal P2 receptor profile and ATP-mediated calcium response from podocytes in glomeruli from kidneys with type 1 or type 2 diabetic kidney disease (DKD), using type 2 diabetic nephropathy (T2DN) rats and streptozotocin-injected Dahl salt-sensitive (type 1 diabetes) rats. A dramatic increase in the ATP-mediated intracellular calcium flux in podocytes was observed in both models. Pharmacological inhibition established that P2X(4) and P2X(7) are the major receptors contributing to the augmented ATP-mediated intracellular calcium signaling in diabetic podocytes. The transition in purinergic receptor composition from metabotropic to ionotropic may disrupt intracellular calcium homeostasis in podocytes resulting in their dysfunction and potentially further aggravating DKD progression.
format Online
Article
Text
id pubmed-8188476
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81884762021-06-16 Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys Palygin, Oleg Klemens, Christine A. Isaeva, Elena Levchenko, Vladislav Spires, Denisha R. Dissanayake, Lashodya V. Nikolaienko, Oksana Ilatovskaya, Daria V. Staruschenko, Alexander iScience Article Growing evidence suggests that renal purinergic signaling undergoes significant remodeling during pathophysiological conditions such as diabetes. This study examined the renal P2 receptor profile and ATP-mediated calcium response from podocytes in glomeruli from kidneys with type 1 or type 2 diabetic kidney disease (DKD), using type 2 diabetic nephropathy (T2DN) rats and streptozotocin-injected Dahl salt-sensitive (type 1 diabetes) rats. A dramatic increase in the ATP-mediated intracellular calcium flux in podocytes was observed in both models. Pharmacological inhibition established that P2X(4) and P2X(7) are the major receptors contributing to the augmented ATP-mediated intracellular calcium signaling in diabetic podocytes. The transition in purinergic receptor composition from metabotropic to ionotropic may disrupt intracellular calcium homeostasis in podocytes resulting in their dysfunction and potentially further aggravating DKD progression. Elsevier 2021-05-11 /pmc/articles/PMC8188476/ /pubmed/34142040 http://dx.doi.org/10.1016/j.isci.2021.102528 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Palygin, Oleg
Klemens, Christine A.
Isaeva, Elena
Levchenko, Vladislav
Spires, Denisha R.
Dissanayake, Lashodya V.
Nikolaienko, Oksana
Ilatovskaya, Daria V.
Staruschenko, Alexander
Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys
title Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys
title_full Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys
title_fullStr Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys
title_full_unstemmed Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys
title_short Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys
title_sort characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188476/
https://www.ncbi.nlm.nih.gov/pubmed/34142040
http://dx.doi.org/10.1016/j.isci.2021.102528
work_keys_str_mv AT palyginoleg characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT klemenschristinea characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT isaevaelena characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT levchenkovladislav characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT spiresdenishar characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT dissanayakelashodyav characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT nikolaienkooksana characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT ilatovskayadariav characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys
AT staruschenkoalexander characterizationofpurinergicreceptor2signalinginpodocytesfromdiabetickidneys